Newly Formed Azidex Pharmaceuticals, Inc. Gets $500K Seed Round From PA Early Stage Partners
10/19/2005 5:09:15 PM
9/8/2005. Azidex Pharmaceuticals Inc., a developer of HIV drugs to treat viral strains resistant to existing medications such as azidothymidine, or AZT, said it received $500,000 of seed financing from PA Early Stage Partners.
comments powered by